SAN DIEGO--(BUSINESS WIRE)--Zogenix, Inc., a privately held CNS-focused specialty pharmaceutical company, announced today that J.D. Haldeman has been appointed vice president, Commercial Strategy and Corporate Communications, and an officer of the company.
